Profile data is unavailable for this security.
About the company
Virax Biolabs Group Limited is a biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. The Company is engaged in developing a T-Cell Test technologies with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against global viral threats. Its product portfolio includes ViraxClear and Virax Immune. ViraxClear offers a range of accurate diagnostic testing kits and machines. Virax Immune is a new Covid-19 test seeking detection of T-Cell immune responses to the SARS-Cov-2 virus. Its T-Cell testing is effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Monkeypox, Hepatitis B, Malaria, Herpes and Human Papillomavirus.
- Revenue in USD (TTM)0.00
- Net income in USD-1.71m
- Incorporated2021
- Employees5.00
- LocationVirax Biolabs Group LtdBiocity Glasgow, Bo'ness Road, NewhouseLONDON ML1 5UHUnited KingdomGBR
- Phone+44 207 788 7414
- Websitehttps://www.viraxbiolabs.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Procyon Corp | 4.70m | -314.48k | 1.69m | 17.00 | -- | 0.7597 | -- | 0.3597 | -0.0388 | -0.0388 | 0.5804 | 0.2901 | 1.40 | 1.95 | 8.58 | 276,481.20 | -8.90 | 3.52 | -10.60 | 4.23 | 77.60 | 73.30 | -6.35 | 2.52 | 2.70 | -- | 0.00 | -- | -3.22 | 3.11 | 70.44 | -- | 30.98 | -- |
| CTT Pharmaceutical Holdings Inc | 0.00 | -1.67m | 1.75m | 0.00 | -- | 0.9821 | -- | -- | -0.0822 | -0.0822 | 0.00 | 0.0346 | 0.00 | -- | -- | -- | -317.28 | 13.49 | -448.83 | 304.48 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -3,454.52 | -- | -- | -- |
| Qualigen Therapeutics Inc | 0.00 | -12.48m | 1.79m | 4.00 | -- | -- | -- | -- | -2.46 | -2.64 | 0.00 | -0.3923 | 0.00 | -- | -- | 0.00 | -118.15 | -- | -364.72 | -- | 21.30 | -- | -- | -- | -- | -7.41 | -- | -- | -- | -- | 10.22 | -- | -- | -- |
| Panbela Therapeutics Inc | 0.00 | -25.26m | 1.84m | 7.00 | -- | -- | -- | -- | -184.67 | -184.67 | 0.00 | -9.81 | 0.00 | -- | -- | 0.00 | -301.11 | -215.89 | -- | -476.38 | -- | -- | -- | -- | -- | -132.20 | 10.73 | -- | -- | -- | 27.68 | -- | -- | -- |
| Target Group Inc | 3.72m | -323.67k | 1.85m | 49.00 | -- | -- | 3.79 | 0.4976 | -0.0008 | -0.0008 | 0.0058 | -0.0113 | 0.4535 | 3.40 | 7.20 | 75,921.84 | -3.95 | -37.99 | -- | -78.76 | 44.49 | -- | -8.70 | -586.97 | 0.1288 | -0.4664 | 2.57 | -- | -- | 577.83 | 92.84 | -- | -58.54 | -- |
| Allarity Therapeutics Inc | 0.00 | -20.42m | 1.89m | 5.00 | -- | -- | -- | -- | -4,118.49 | -4,118.49 | 0.00 | -9.35 | 0.00 | -- | -- | 0.00 | -90.14 | -- | -2,340.41 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 3.02 | -- | -- | -- |
| Virax Biolabs Group Ltd | 0.00 | -1.71m | 1.89m | 5.00 | -- | -- | -- | -- | -1.50 | -1.50 | 0.00 | -0.8568 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 0.0223 | -112.29 | -- | -- | -100.00 | -- | -162.50 | -- | -- | -- |
| SOHM Inc | -100.00bn | -100.00bn | 1.92m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| PainReform Ltd | 0.00 | -9.34m | 1.93m | 6.00 | -- | 0.1862 | -- | -- | -7.21 | -7.21 | 0.00 | 4.19 | 0.00 | -- | -- | 0.00 | -83.96 | -55.47 | -99.49 | -68.20 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -6.28 | -- | -- | -- |
| Aclarion Inc | 75.41k | -4.91m | 1.98m | 6.00 | -- | -- | -- | 26.24 | -9.36 | -9.36 | 0.1434 | -0.8819 | 0.0281 | -- | 4.74 | 12,568.33 | -182.77 | -- | -655.74 | -- | -0.4244 | -- | -6,512.90 | -- | -- | -- | 2.83 | -- | 24.75 | -- | 34.38 | -- | -- | -- |
| Limitless X Holdings Inc | 20.06m | -16.12m | 1.99m | 12.00 | -- | -- | -- | 0.0992 | -4.06 | -4.06 | 5.06 | -3.24 | 3.30 | 2.31 | 39.61 | 1,671,340.00 | -265.35 | -- | -- | -- | 77.66 | -- | -80.37 | -- | 0.0186 | -15.77 | -- | -- | -65.83 | -- | -60.80 | -- | -- | -- |
| CYANOTECH CORP | 22.49m | -4.62m | 2.02m | 86.00 | -- | 0.1446 | -- | 0.0896 | -0.7265 | -0.7265 | 3.53 | 2.01 | 0.7889 | 1.53 | 10.73 | 261,546.50 | -16.19 | -2.32 | -21.07 | -2.96 | 29.59 | 35.88 | -20.52 | -2.33 | 0.3702 | -5.93 | 0.3299 | -- | -35.56 | -7.44 | -259.70 | -- | 1.22 | -- |
| cbdMD Inc | 23.45m | -23.98m | 2.06m | 52.00 | -- | 0.7652 | -- | 0.0878 | -20.34 | -20.34 | 12.19 | 0.8839 | 0.9227 | 2.06 | 23.44 | 450,876.20 | -78.62 | -38.59 | -101.68 | -41.50 | 63.84 | 63.80 | -85.21 | -87.98 | 0.6383 | -9.92 | 0.00 | -- | -31.77 | 120.91 | 63.64 | -- | -4.95 | -- |
| CNS Pharmaceuticals Inc | 0.00 | -18.85m | 2.08m | 3.00 | -- | -- | -- | -- | -5.76 | -5.76 | 0.00 | -0.7132 | 0.00 | -- | -- | 0.00 | -255.54 | -132.47 | -1,018.78 | -185.75 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -23.42 | -- | -- | -- |
Data as of May 10 2024. Currency figures normalised to Virax Biolabs Group Ltd's reporting currency: US Dollar USD
5.65%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Armistice Capital LLCas of 31 Dec 2023 | 122.00k | 5.17% |
| Virtu Americas LLCas of 31 Dec 2023 | 10.64k | 0.45% |
| UBS Securities LLCas of 31 Dec 2023 | 665.00 | 0.03% |
| Wells Fargo Clearing Services LLCas of 31 Mar 2024 | 100.00 | 0.00% |
| Citadel Securities LLCas of 31 Dec 2023 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
